146 related articles for article (PubMed ID: 36748330)
21. Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma.
Liang C; Hu W; Li J; Zhang X; Zhou Z; Liang Y
Dermatol Ther; 2021 Jul; 34(4):e14981. PubMed ID: 33993602
[TBL] [Abstract][Full Text] [Related]
22. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
[TBL] [Abstract][Full Text] [Related]
23. Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study.
Barreiro-Capurro A; Andrés-Lencina JJ; Podlipnik S; Carrera C; Requena C; Manrique-Silva E; Quaglino P; Tonella L; Jaka A; Richarz N; Rodríguez-Peralto JL; Ortiz P; Boada A; Ribero S; Nagore E; Malvehy J; Puig S
Eur J Cancer; 2021 Mar; 145():29-37. PubMed ID: 33418234
[TBL] [Abstract][Full Text] [Related]
24. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
[TBL] [Abstract][Full Text] [Related]
25. Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit.
Karlsson A; Ellonen A; Irjala H; Väliaho V; Mattila K; Nissi L; Kytö E; Kurki S; Ristamäki R; Vihinen P; Laitinen T; Ålgars A; Jyrkkiö S; Minn H; Heervä E
ESMO Open; 2021 Jun; 6(3):100175. PubMed ID: 34091262
[TBL] [Abstract][Full Text] [Related]
26. Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal study.
Tedman AJ; Liyanage UE; Chong S; Rowe C; von Schuckmann LA; Malt M; Green AC; Smithers BM; Khosrotehrani K
Australas J Dermatol; 2023 Feb; 64(1):e34-e40. PubMed ID: 36651479
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
28. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
[TBL] [Abstract][Full Text] [Related]
29. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry.
Sarac E; Amaral T; Keim U; Leiter U; Forschner A; Eigentler TK; Garbe C
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2021-2025. PubMed ID: 32078189
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
32. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
[TBL] [Abstract][Full Text] [Related]
35. Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma.
Meyer S; Buser L; Haferkamp S; Berneburg M; Maisch T; Klinkhammer-Schalke M; Pauer A; Vogt T; Garbe C
Eur J Cancer; 2023 Mar; 182():77-86. PubMed ID: 36753835
[TBL] [Abstract][Full Text] [Related]
36. A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
Sood A; Wykes J; Roshan D; Wang LY; McGuinness J; Fowler A; Ebrahimi A
Head Neck; 2019 Jun; 41(6):1591-1596. PubMed ID: 30659690
[TBL] [Abstract][Full Text] [Related]
37. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Hoshimoto S; Shingai T; Morton DL; Kuo C; Faries MB; Chong K; Elashoff D; Wang HJ; Elashoff RM; Hoon DS
J Clin Oncol; 2012 Nov; 30(31):3819-26. PubMed ID: 23008288
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor.
El Sharouni MA; Stodell MD; Ahmed T; Suijkerbuijk KPM; Cust AE; Witkamp AJ; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; van Gils CH; Lo SN
Ann Oncol; 2021 Mar; 32(3):375-383. PubMed ID: 33253862
[TBL] [Abstract][Full Text] [Related]
39. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
40. Multicenter evaluation of patients with cutaneous malignant melanoma in Turkey: MELAS study.
Uysal-Sonmez O; Tanriverdi O; Esbah O; Uyeturk U; Helvaci K; Bal O; Yalcintas-Arslan U; Budakoglu B; Oksuzoglu B
Asian Pac J Cancer Prev; 2013; 14(1):533-7. PubMed ID: 23534790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
